Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Doxofylline (400mg)
Therapeutic Category
Asthma, Pulmonary, Respiratory
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹102/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dozyfyle 400 Tablet is an effective respiratory medication primarily designed to relieve symptoms associated with asthma and chronic obstructive pulmonary disease (COPD). It contains 400 mg of doxofylline, a methylxanthine derivative that acts as a bronchodilator, helping to relax and open the airways in the lungs. This action facilitates easier breathing and helps alleviate coughing, wheezing, and shortness of breath.
Doxofylline works by inhibiting phosphodiesterase enzymes, which leads to increased levels of cyclic AMP (cAMP) in airway smooth muscle cells. This increase results in relaxation of the bronchial muscles, thus improving airflow. Dozyfyle 400 Tablet is particularly beneficial for patients who may not respond well to other bronchodilators, offering a different mechanism of action to provide symptomatic relief.
Common side effects may include nausea, headache, dizziness, and palpitations. Serious side effects are rare but can include allergic reactions and severe cardiovascular events.
Dozyfyle 400 Tablet is indicated for the management of bronchial asthma and COPD.
Consult your healthcare provider before use, especially if you have a history of heart conditions or are pregnant or breastfeeding.
Store in a cool, dry place away from direct sunlight and out of reach of children.
Composition : Doxofylline (400mg) + Ambroxol (30mg)
Composition : Doxofylline (400mg) + Montelukast (10mg)
Composition : Doxofylline (650mg) SR
Composition : Formoterol (12mcg) + Tiotropium (18mcg)
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Composition : Levosalbutamol (50mcg) + Ipratropium (20mcg)
Composition : Tiotropium (9mcg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Doxofylline 400mg Tablet has strong demand in the respiratory segment, making it a useful prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in asthma, COPD (chronic obstructive pulmonary disease), bronchospasm, wheezing, and chronic respiratory disorders. It is widely prescribed by physicians and pulmonologists for long-term airway management.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Doxofylline 400mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady prescription demand, seasonal respiratory sales peaks, and strong acceptance in pulmonology and general practice when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.